Seroclearance of Hepatitis B surface antigen after entecavir treatment

被引：0
作者：
Halichidis, Stela [1 ]
Dumea, Elena [1 ]
Cambrea, Claudia S. [1 ]
机构：
[1] Clin Infect Dis Hosp, Constanta, Romania
来源：
JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES | 2013年 / 22卷 / 02期
关键词：
TENOFOVIR DISOPROXIL FUMARATE; HBEAG-POSITIVE PATIENTS; ADEFOVIR DIPIVOXIL;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：236 / 236
页数：1
相关论文
共 50 条
  • [31] Systematic review with meta-analysis: combination treatment of regimens based on pegylated interferon for chronic hepatitis B focusing on hepatitis B surface antigen clearance
    Qiu, K.
    Liu, B.
    Li, S. -Y.
    Li, H.
    Chen, Z. -W.
    Luo, A. -R.
    Peng, M-L.
    Ren, H.
    Hu, P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (10) : 1340 - 1348
  • [32] Tenofovir Disoproxil Fumarate Is Superior to Entecavir in Reducing Hepatitis B Surface Antigen for Chronic Hepatitis B in China: 2-Year Comprehensive Comparative Result of a Matched Comparative Study
    Yang, Sisi
    Ma, Xueqing
    Cai, Chengwei
    Wang, Huanqiu
    Xiao, Fenqiang
    Yu, Chengbo
    FRONTIERS IN MEDICINE, 2021, 8
  • [33] Incidence and factors associated with hepatitis B surface antigen seroclearance in patients co-infected with HBV/HIV during antiretroviral therapy in Guangdong, China
    He, Yaozu
    Lin, Weiyin
    Li, Hong
    Gu, Fei
    Zhong, Huolin
    Lan, Yun
    Li, Yonghong
    Guo, Pengle
    Hu, Fengyu
    Cai, Weiping
    Tang, Xiaoping
    Li, Linghua
    CHINESE MEDICAL JOURNAL, 2023, 136 (22) : 2686 - 2693
  • [34] Loss of HBsAg antigen during treatment with entecavir or lamivudine in nucleoside-naive HBeAg-positive patients with chronic hepatitis B
    Gish, R. G.
    Chang, T. -T.
    Lai, C. -L.
    de Man, R.
    Gadano, A.
    Poordad, F.
    Yang, J.
    Brett-Smith, H.
    Tamez, R.
    JOURNAL OF VIRAL HEPATITIS, 2010, 17 (01) : 16 - 22
  • [35] Efficacy of entecavir treatment for lamivudine-resistant hepatitis B over 3 years: Histological improvement or entecavir resistance?
    Suzuki, Yoshiyuki
    Suzuki, Fumitaka
    Kawamura, Yusuke
    Yatsuji, Hiromi
    Sezaki, Hitomi
    Hosaka, Tetsuya
    Akuta, Norio
    Kobayashi, Masahiro
    Saitoh, Satoshi
    Arase, Yasuji
    Ikeda, Kenji
    Kobayashi, Mariko
    Miyakawa, Yuzo
    Kumada, Hiromitsu
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 (03) : 429 - 435
  • [36] Changes of HBsAg and HBV DNA levels in Chinese chronic hepatitis B patients after 5 years of entecavir treatment
    Seto, Wai-Kay
    Lam, Yuk-Fai
    Fung, James
    Wong, Danny Ka-Ho
    Huang, Fung-Yu
    Hung, Ivan Fan-Ngai
    Lai, Ching-Lung
    Yuen, Man-Fung
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 (05) : 1028 - 1034
  • [37] Hepatitis B surface antigen: carcinogenesis mechanisms and clinical implications in hepatocellular carcinoma
    Hao, Bingyan
    Liu, Yachong
    Wang, Bohan
    Wu, Haofeng
    Chen, Yan
    Zhang, Lei
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2025, 14 (01)
  • [38] Association of on-treatment serum hepatitis B surface antigen level with sustained virological response to nucleos(t)ide analog in patients with hepatitis B e-antigen positive chronic hepatitis B
    Kim, Soon Sun
    Lee, Dami
    Lee, Myoung Hee
    Cheong, Jae Youn
    Cho, Sung Won
    HEPATOLOGY RESEARCH, 2013, 43 (03) : 219 - 227
  • [39] The efficacy of adefovir dipivoxil, entecavir and telbivudine for chronic hepatitis B treatment: a systematic review
    Almeida, Alessandra Maciel
    Ribeiro, Andreia Queiroz
    Menezes de Padua, Cristiane Aparecida
    Ruas Brandao, Cristina Mariano
    Gurgel Andrade, Eli Iola
    Cherchiglia, Mariangela Leal
    Carmo, Ricardo Andrade
    Acurcio, Francisco de Assis
    REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2010, 43 (04) : 440 - 451
  • [40] Partial virological response to entecavir in treatment-naive patients with chronic hepatitis B
    Chon, Young Eun
    Kim, Seung Up
    Lee, Chun Kyon
    Heo, Jeong
    Kim, Ja Kyung
    Yoon, Ki Tae
    Cho, Mong
    Lee, Kwan Sik
    Kim, Dong Hwan
    Choi, Eun Hee
    Park, Jun Yong
    Kim, Do Young
    Chon, Chae Yoon
    Han, Kwang-Hyub
    Ahn, Sang Hoon
    ANTIVIRAL THERAPY, 2011, 16 (04) : 469 - 477
12345